Login / Signup

Lysosomal diseases: Overview on current diagnosis and treatment.

Fabiano de Oliveira PoswarFilippo Pinto E VairoMaira BurinKristiane Michelin-TirelliAna Carolina Brusius-FacchinFrancyne KubaskiCarolina Fischinger Moura de SouzaGuilherme BaldoRoberto Giugliani
Published in: Genetics and molecular biology (2019)
Lysosomal diseases (LDs), also known as lysosomal storage diseases (LSDs), are a heterogeneous group of conditions caused by defects in lysosomal function. LDs may result from deficiency of lysosomal hydrolases, membrane-associated transporters or other non-enzymatic proteins. Interest in the LD field is growing each year, as more conditions are, or will soon be treatable. In this article, we review the diagnosis of LDs, from clinical suspicion and screening tests to the identification of enzyme or protein deficiencies and molecular genetic diagnosis. We also cover the treatment approaches that are currently available or in development, including hematopoietic stem cell transplantation, enzyme replacement therapy, small molecules, and gene therapy.
Keyphrases
  • replacement therapy
  • gene therapy
  • smoking cessation
  • acute myeloid leukemia
  • hydrogen peroxide
  • genome wide
  • gene expression
  • dna methylation
  • copy number
  • amino acid